Thursday, April 08, 2021 6:30:07 PM
Agree with NJ & Bunions but if it's massive dilution then scrap Phase III. The risk reward ain't worth it with this outfit at the helm. Remembering the CEO spouting over and over and over about Bellus Health being a "pure comparator and 500M market caps before Phase III and the biggie - Everybody wants in at Phase II.
Yeah, the CEO got none of that right.
Mackie Research wont even give the IPF/CC angle anything more than a 20 cent per share valuation.
That includes everything else in the pipeline.
Think about that.
They are basically saying the entire pipeline including DMT is trash.
The CEO ain't said jack about that in the Facebook Live webcast.
He's fine with letting Mackie Research trash the stock.
Christopher Moreau is a weak weak weak CEO.
Meanwhile, the question I'd ask is like a riddle or something.
The CEO thus far being flat out wrong in ALL of his rhetoric about what the market will do - should we look at it from the exact opposite?
Everybody wants out at Phase II but everybody wants in at Phase III?
As the AP story continues to play out (drip drip drip) you can bet the farm there will be lots of drama \|/ @ AP.
Holla @ me
M$
Outro
Yeah, the CEO got none of that right.
Mackie Research wont even give the IPF/CC angle anything more than a 20 cent per share valuation.
That includes everything else in the pipeline.
Think about that.
They are basically saying the entire pipeline including DMT is trash.
The CEO ain't said jack about that in the Facebook Live webcast.
He's fine with letting Mackie Research trash the stock.
Christopher Moreau is a weak weak weak CEO.
Meanwhile, the question I'd ask is like a riddle or something.
The CEO thus far being flat out wrong in ALL of his rhetoric about what the market will do - should we look at it from the exact opposite?
Everybody wants out at Phase II but everybody wants in at Phase III?
As the AP story continues to play out (drip drip drip) you can bet the farm there will be lots of drama \|/ @ AP.
Holla @ me
M$
Outro
Recent AGNPF News
- Algernon Health Announces Proposed Name Change to “Grey Matters Health Inc.” and a 10:1 Share Consolidation • GlobeNewswire Inc. • 03/31/2026 11:09:55 PM
- Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers • GlobeNewswire Inc. • 03/25/2026 11:00:00 AM
- Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building • GlobeNewswire Inc. • 03/23/2026 11:00:00 AM
- Algernon Announces Additional Increase to Private Placement Financing to $858,000 and Final Closing of the Financing • GlobeNewswire Inc. • 12/31/2025 09:01:00 PM
- Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche • GlobeNewswire Inc. • 12/23/2025 09:01:00 PM
- Form D/A - Notice of Exempt Offering of Securities: [Amend] • Edgar (US Regulatory) • 12/09/2025 05:01:20 PM
- Algernon Closes Second Tranche of Private Placement Financing • GlobeNewswire Inc. • 11/29/2025 12:51:39 AM
- Algernon Health and American Molecular Imaging Announce Strategic Business and USD $500K Investment Agreement • GlobeNewswire Inc. • 11/17/2025 12:00:00 PM
- Algernon Closes First Tranche of its Recently Announced Private Placement Financing • GlobeNewswire Inc. • 11/15/2025 12:55:26 AM
- Algernon Health Announces Private Placement • GlobeNewswire Inc. • 11/06/2025 12:04:28 PM
- Algernon Pharmaceuticals Completes Name Change to Algernon Health • GlobeNewswire Inc. • 10/15/2025 11:00:00 AM
- Algernon Announces CAD $4 Million Non-Dilutive Financing to Open Four Brain-Specific PET Scan Clinics in the U.S. for Early Stage Alzheimer’s Detection • GlobeNewswire Inc. • 09/25/2025 11:00:00 AM
- Algernon Announces Preferred Share Class Approved at Annual and Special Meeting • GlobeNewswire Inc. • 09/19/2025 08:39:57 PM

